Psilocybin, psychological distress, and suicidality
- PMID: 26395582
- PMCID: PMC4721603
- DOI: 10.1177/0269881115598338
Psilocybin, psychological distress, and suicidality
Conflict of interest statement
Comment on
-
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.J Psychopharmacol. 2015 Mar;29(3):280-8. doi: 10.1177/0269881114565653. Epub 2015 Jan 13. J Psychopharmacol. 2015. PMID: 25586402
References
-
- Bogenschutz MP, Forcehimes AA, Pommy JA, et al. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. J Psychopharmacol. 2015;29:289–299. - PubMed
-
- Gable RS. Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used non-medically. Am J Drug Alcohol Abuse. 1993;19:263–281. - PubMed
-
- Gable RS. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction. 2004;99:686–696. - PubMed
-
- Grob CS, Danforth AL, Chopra GS, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011;68:71–78. - PubMed
-
- Hendricks PS, Thorne CB, Clark CB, et al. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. J Psychopharmacol. 2015;29:280–288. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
